Eljoint 50mg Tablet
Marketer
Elfin Pharma Pvt Ltd
Salt Composition
Diacerein (50mg)
Overview Eljoint 50mg Tablet
Osteoarthritis is treated with ArthriCare 50mg tablets, which reduce pain and inflammation, promoting faster joint recovery. This medication can be used independently or alongside other treatments. ArthriCare 50mg should be taken with meals, consistently at the same time daily. Therapeutic effects may take several weeks to manifest. Concurrent regular exercise, focusing on strengthening muscles surrounding affected joints and weight management, is recommended. Discontinuing ArthriCare 50mg abruptly requires prior consultation with your physician. Minor side effects, including altered urine color or diarrhea, may occur. Regular blood glucose monitoring is crucial for diabetic patients, as this medication can elevate blood sugar levels.
Primary Ingredients of Eljoint 50mg Tablet
No text provided. Please provide the text you wish me to rewrite.
Uses of Eljoint 50mg Tablet
Degenerative joint disease
Major Benefits of Eljoint 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 50mg Eljoint Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Eljoint 50mg Tablet:
- Diarrhea
- Urine discoloration
How to use Eljoint 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 50mg Eljoint Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Eljoint 50mg Tablet works:
Eljoint 50mg tablets promote cartilage regeneration by stimulating proteoglycan synthesis. This action facilitates joint repair and provides relief from pain and inflammation.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Eljoint 50mg Tablet with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Eljoint 50mg tablets during pregnancy may pose risks. While human studies are scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Eljoint 50mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Eljoint 50mg Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Eljoint 50mg tablets are likely safe for individuals with kidney conditions. Existing evidence indicates dose modification may not be necessary, though this is based on limited information. Physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Eljoint 50mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eljoint 50mg Tablet :
Omit any missed Eljoint 50mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Eljoint 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Anthracene Carboxylic Acids |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
3,018 People bought this recently